Mitigating cellular inflammation in older adults: a randomized controlled trial of Tai Chi Chih
- PMID: 21934474
- PMCID: PMC3247625
- DOI: 10.1097/JGP.0b013e3182330fd3
Mitigating cellular inflammation in older adults: a randomized controlled trial of Tai Chi Chih
Abstract
Objectives: To evaluate the effects of a behavioral intervention, Tai Chi Chih (TCC) on circulating markers of inflammation in older adults.
Design: A prospective, randomized, controlled trial with allocation to two arms, TCC and health education (HE), 16 weeks of intervention administration, and 9 weeks follow-up.
Participants: A total of 83 healthy older adults, aged 59 to 86 years.
Measurements: The primary endpoint was circulating levels of interleukin 6 (IL-6). Secondary outcomes were circulating levels of C-reactive protein, soluble IL-1 receptor antagonist, soluble IL-6 receptor, soluble intercellular adhesion molecule, and IL-18. Severity of depressive symptoms, sleep quality, and physical activity was also assessed over the treatment trial.
Results: Among those older adults with high levels of IL-6 at entry, a trend for a treatment group by time interaction was found (F[1,70] = 3.48, p = 0.07), in which TCC produced a drop of IL-6 levels comparable to those found in TCC and HE subgroups who had low levels of IL-6 at entry (t72's = 0.80, 1.63, p's >0.10), whereas IL-6 in HE remained higher than the TCC and HE subgroups with low entry IL-6 (t72 = 2.47, p = 0.02; t72 = 1.71, p = 0.09). Decreases in depressive symptoms in the two treatment groups correlated with decreases of IL-6 (r = 0.28, p <0.05). None of the other cellular markers of inflammation changed in TCC versus HE.
Conclusion: TCC can be considered a useful behavioral intervention to reduce circulating levels of IL-6 in older adults who show elevated levels of this inflammatory marker and are at risk for inflammation-related morbidity.
Trial registration: ClinicalTrials.gov NCT00118885.
Conflict of interest statement
Dr. Irwin, the corresponding author, has had full access to all the data in the study and has final responsibility for the decision to submit for publication. Drs. Irwin and Olmstead declare that they have no conflicts of interest.
Figures


Similar articles
-
Cognitive behavioral therapy and tai chi reverse cellular and genomic markers of inflammation in late-life insomnia: a randomized controlled trial.Biol Psychiatry. 2015 Nov 15;78(10):721-9. doi: 10.1016/j.biopsych.2015.01.010. Epub 2015 Feb 4. Biol Psychiatry. 2015. PMID: 25748580 Free PMC article. Clinical Trial.
-
Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial.Sleep. 2014 Sep 1;37(9):1543-52. doi: 10.5665/sleep.4008. Sleep. 2014. PMID: 25142571 Free PMC article. Clinical Trial.
-
Improved sleep quality in older adults with insomnia reduces biomarkers of disease risk: pilot results from a randomized controlled comparative efficacy trial.Psychoneuroendocrinology. 2015 May;55:184-92. doi: 10.1016/j.psyneuen.2015.02.010. Epub 2015 Feb 25. Psychoneuroendocrinology. 2015. PMID: 25770704 Free PMC article. Clinical Trial.
-
Impact of Tai Chi on CRP, TNF-alpha and IL-6 in inflammation: a systematic review and meta-analysis.Ann Palliat Med. 2021 Jul;10(7):7468-7478. doi: 10.21037/apm-21-640. Ann Palliat Med. 2021. PMID: 34353036
-
Optimal exercise parameters of tai chi for balance performance in older adults: A meta-analysis.J Am Geriatr Soc. 2021 Jul;69(7):2000-2010. doi: 10.1111/jgs.17094. Epub 2021 Mar 26. J Am Geriatr Soc. 2021. PMID: 33769556
Cited by
-
Effect of physical activity on anxiety and depression in COVID-19 adults: A systematic review and meta-analysis.iScience. 2024 Aug 30;27(10):110844. doi: 10.1016/j.isci.2024.110844. eCollection 2024 Oct 18. iScience. 2024. PMID: 39429776 Free PMC article.
-
Dao Yin (a.k.a. Qigong): Origin, Development, Potential Mechanisms, and Clinical Applications.Evid Based Complement Alternat Med. 2019 Oct 21;2019:3705120. doi: 10.1155/2019/3705120. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31772593 Free PMC article. Review.
-
Stress, inflammation, and aging.Am J Geriatr Psychiatry. 2012 Sep;20(9):729-33. doi: 10.1097/JGP.0b013e31826573cf. Am J Geriatr Psychiatry. 2012. PMID: 22874577 Free PMC article.
-
Beneficial Effects and Potential Mechanisms of Tai Chi on Lower Limb Osteoarthritis: A Biopsychosocial Perspective.Chin J Integr Med. 2023 Apr;29(4):368-376. doi: 10.1007/s11655-021-3529-9. Epub 2021 Dec 18. Chin J Integr Med. 2023. PMID: 34921649 Review.
-
Cognitive behavioral therapy and tai chi reverse cellular and genomic markers of inflammation in late-life insomnia: a randomized controlled trial.Biol Psychiatry. 2015 Nov 15;78(10):721-9. doi: 10.1016/j.biopsych.2015.01.010. Epub 2015 Feb 4. Biol Psychiatry. 2015. PMID: 25748580 Free PMC article. Clinical Trial.
References
-
- Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639–646. - PubMed
-
- Thomas DR. The relationship between functional status and inflammatory disease in older adults. J Gerontol A Biol Sci Med Sci. 2003;58:995–998. - PubMed
-
- Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39:687–699. - PubMed
-
- Butcher SK, Lord JM. Stress responses and innate immunity: aging as a contributory factor. Aging Cell. 2004;3:151–160. - PubMed
-
- Franceschi C, Bonafe M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine. 2000;18:1717–1720. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- R21-AT00255/AT/NCCIH NIH HHS/United States
- P30-AG028748/AG/NIA NIH HHS/United States
- R01-AG 026364/AG/NIA NIH HHS/United States
- M01 RR000865/RR/NCRR NIH HHS/United States
- UL1 TR000124/TR/NCATS NIH HHS/United States
- P30 AG028748/AG/NIA NIH HHS/United States
- R01-AG 18367/AG/NIA NIH HHS/United States
- R01 HL079955/HL/NHLBI NIH HHS/United States
- R01 CA119159/CA/NCI NIH HHS/United States
- R01 AG026364/AG/NIA NIH HHS/United States
- T32 MH018399/MH/NIMH NIH HHS/United States
- T32-MH18399/MH/NIMH NIH HHS/United States
- R01 AG018367/AG/NIA NIH HHS/United States
- R01-AG 034588/AG/NIA NIH HHS/United States
- T32 MH019925/MH/NIMH NIH HHS/United States
- R01 HL 079955/HL/NHLBI NIH HHS/United States
- R01-CA 10014152/CA/NCI NIH HHS/United States
- R21 AT000255/AT/NCCIH NIH HHS/United States
- M01-RR00865/RR/NCRR NIH HHS/United States
- R01 AG034588/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous